ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
On the Trail of Parkinson's Disease
April 01, 2017The human brain contains large quantities of the small alpha-synuclein protein. Its exact biological function is still unknown, yet it is closely linked to Parkinson's disease; the protein "clumps together" in the nerve cells of Parkinson patients. -
FDA clears Newron, Zambon, US WorldMeds' Xadago for Parkinson's disease
March 22, 2017The FDA approved Newron Pharmaceuticals, Zambon and US WorldMeds' Xadago (safinamide) as an add-on therapy to levodopa/carbidopa for patients with Parkinson's disease, the companies announced Tuesday. -
Acorda's experimental Parkinson's disease drug CVT-301 hits main goal of late-stage trial
February 10, 2017Acorda Therapeutics' experimental drug CVT-301 demonstrated a significant improvement in motor function versus placebo in people with Parkinson's disease experiencing OFF periods in a Phase III study, the company reported. -
Zambon and Seqirus partner for Parkinson's disease product in Australia and New Zealand
January 13, 2017Italian company Zambon and Australian-based Seqirus have collaborated for Parkinson's disease (PD) product, Xadago, in Australia and New Zealand.
Pharma Sources Insight January 2025
